<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Results</title>
    <link rel="stylesheet" href="./lib/css/styles.css">
</head>
<body class="results">
<p><strong>Colorectal&nbsp; cancer&nbsp; detection.&nbsp; Moderate-risk&nbsp; individual.&nbsp; Average-risk&nbsp; individual&nbsp; after&nbsp; positive&nbsp; fecal occult blood test (FOBT) or positive fecal immunochemical test indicating a relative elevation in risk.</strong></p>
<p><strong>&nbsp;</strong></p>
<p><strong>CT Colonography is usually not appropriate.</strong></p>
<p><strong>DCBE or MR may be appropriate.</strong></p>
<p><strong>SCBE is usually not appropriate.</strong></p>
<p><strong>&nbsp;</strong></p>
<p><strong>CT colonography&nbsp; - CTC;</strong></p>
<p>CTC&nbsp; also&nbsp; performs&nbsp; well&nbsp; in&nbsp; individuals&nbsp; with&nbsp; positive&nbsp; stool-based&nbsp; screening&nbsp; tests.&nbsp; A&nbsp; meta-analysis&nbsp; of &nbsp;5&nbsp; articles&nbsp; published&nbsp; between&nbsp; 2009&nbsp; and&nbsp; 2011&nbsp; showed&nbsp; that&nbsp; CTC&nbsp; had&nbsp; a&nbsp; per-patient&nbsp; sensitivity&nbsp; of&nbsp; 88.8%&nbsp; (95%&nbsp; CI,&nbsp; 83.6%&nbsp; to&nbsp; 92.5%)&nbsp; for&nbsp; &ge;6-mm&nbsp; adenomas&nbsp; or&nbsp; colorectal&nbsp; cancer&nbsp; with&nbsp; average&nbsp; specificity&nbsp; of&nbsp; 75.4%&nbsp; (95%&nbsp; CI,&nbsp; 58.6%&nbsp; to&nbsp; 86.8%)&nbsp; for a pooled study population of 622 patients with positive FOBTs either by guaiac or immunochemical methods [81]. This was despite the fact that 2 of the 5 studies in the meta-analysis utilized a cathartic-free approach, which is&nbsp; known&nbsp; to&nbsp; decrease &nbsp;adenoma&nbsp; detection.&nbsp; Fecal&nbsp; tagging&nbsp; was&nbsp; variably&nbsp; used,&nbsp; which&nbsp; may&nbsp; have&nbsp; contributed&nbsp; to&nbsp; the&nbsp; relatively lower specificity [81]. In this meta-analysis, the calculated prevalence for &ge;6-mm adenomas or cancer ranged from 32.0% to 65.3%, leading the authors to suggest that colonoscopy should likely remain the preferred test&nbsp; for&nbsp; FOBT-positive&nbsp; patients&nbsp; when&nbsp; feasible&nbsp; [81].&nbsp; If&nbsp; rates&nbsp; are&nbsp; truly&nbsp; elevated&nbsp; in&nbsp; this&nbsp; range,&nbsp; this&nbsp; would&nbsp; certainly&nbsp; decrease the usefulness of CTC in this scenario where too many individuals would be referred on to colonoscopy. However,&nbsp; it&nbsp; is&nbsp; important&nbsp; to&nbsp; realize&nbsp; that&nbsp; evidence&nbsp; exists&nbsp; that&nbsp; these&nbsp; rates&nbsp; are&nbsp; much&nbsp; lower.&nbsp; A&nbsp; larger&nbsp; observational&nbsp; study&nbsp; (n&nbsp; =&nbsp; 2,731)&nbsp; reported&nbsp; CTC&nbsp; use&nbsp; in&nbsp; FOBT-positive&nbsp; patients&nbsp; within&nbsp; the&nbsp; English&nbsp; Bowel&nbsp; Cancer&nbsp; Screening&nbsp;</p>
<p>ACR Appropriateness Criteria&reg;8 Colorectal Cancer Screening Program.&nbsp; Here,&nbsp; the&nbsp; prevalence&nbsp; for&nbsp; FOBT-positive&nbsp; group&nbsp; was&nbsp; 23.4%&nbsp; for&nbsp; a&nbsp; polyp&nbsp; &ge;6&nbsp; mm&nbsp; in&nbsp; size&nbsp; [82].&nbsp; If&nbsp; the&nbsp; prevalence&nbsp; is&nbsp; more&nbsp; in&nbsp; this&nbsp; range,&nbsp; referral&nbsp; rates&nbsp; from&nbsp; CTC&nbsp; would&nbsp; then&nbsp; be&nbsp; reasonable&nbsp; and&nbsp; allow&nbsp; a&nbsp; CTC-based&nbsp; strategy&nbsp; to&nbsp; decrease&nbsp; numbers&nbsp; of&nbsp; unnecessary&nbsp; nontherapeutic&nbsp; colonoscopies.&nbsp; There&nbsp; is&nbsp; currently&nbsp; no&nbsp; evidence&nbsp; to&nbsp; support or to not support the use of CTC following a positive stool DNA test</p>
<p><strong>X-ray barium enema double-contrast &ndash; DCBE</strong></p>
<p>In&nbsp; symptomatic&nbsp; patients&nbsp; (eg,&nbsp; rectal&nbsp; bleeding,&nbsp; abdominal&nbsp; pain,&nbsp; weight&nbsp; loss),&nbsp; DCBE&nbsp; was&nbsp; found&nbsp; to&nbsp; detect&nbsp; fewer&nbsp; cancers or polyps &ge;10 mm as compared to CTC in a pragmatic multicenter randomized trial of 3,506 symptomatic patients [83]. In a smaller, older study of 154 patients presenting with symptoms and subsequently diagnosed with colorectal&nbsp; carcinoma,&nbsp; DCBE&nbsp; was&nbsp; found&nbsp; to&nbsp; detect&nbsp; 64%&nbsp; of&nbsp; colorectal&nbsp; cancers&nbsp; [84].&nbsp; DCBE&nbsp; was&nbsp; found&nbsp; to&nbsp; have&nbsp; a&nbsp; sensitivity of 85% for the diagnosis of colorectal cancer in 485 patients, the majority of whom were symptomatic [66].In studies comparing DCBE to endoscopy, when used to evaluate individuals with a positive FOBT, most reports indicate a sensitivity of 75% to 80% [85,86]. In a study comparing DCBE to endoscopy in 71 patients with rectal bleeding, the sensitivity of DCBE for detecting adenomas &gt;6 mm was 58% [8</p>
<p><strong>SCBE Single-contrast barium enema (SCBE)</strong></p>
<p>SCBE&nbsp; generally&nbsp; does&nbsp; not&nbsp; perform&nbsp; as&nbsp; well&nbsp; as&nbsp; DCBE&nbsp; for&nbsp; detection&nbsp; of&nbsp; polyps&nbsp; and&nbsp; cancers&nbsp; and&nbsp; should&nbsp; be&nbsp; used&nbsp; if&nbsp; CTC&nbsp; or&nbsp; DCBE&nbsp; cannot&nbsp; be&nbsp; performed.&nbsp; In&nbsp; a&nbsp; retrospective&nbsp; evaluation&nbsp; of&nbsp; 165&nbsp; patients&nbsp; who&nbsp; underwent&nbsp; SCBE,&nbsp; the&nbsp; sensitivity for colorectal cancer was 81.8% [66]. The majority of these patients were symptomatic (eg, bleeding, anemia, altered bowel habit) at time of imaging [66]. In a FOBT trial, SCBE was used as a diagnostic follow-up and the sensitivity for cancer was 80% [88].</p>
<p><strong>MR Colonography Magnetic resonance (MR)</strong></p>
<p>Data regarding the performance of MR colonography in moderate-risk individuals is limited. In a 3-reader study of 98 symptomatic patients (eg, rectal bleeding, change in bowel habits) who underwent both MR colonography with fecal tagging and CO2 insufflation and colonoscopy, per-patient sensitivity for lesions &ge;10 mm ranged from 75% to 92% across the 3 readers with specificity ranging from 95% to 98% [89]. Per-patient sensitivity for lesions &ge;6 mm ranged from 57% to 86% and specificity ranged from 87% to 99%. For advanced neoplasia &ge;6 mm, per-patient sensitivity was 89% and specificity ranged from 97% to 99% [89]. In a study of 24 patients who presented with rectal bleeding, a positive FOBT, or altered bowel habits, MR colonography with barium-based fecal tagging detected&nbsp; all&nbsp; polyps&nbsp; &gt;8&nbsp; mm&nbsp; [90].&nbsp; A&nbsp; tap&nbsp; water&nbsp; enema&nbsp; was&nbsp; used&nbsp; to&nbsp; distend&nbsp; the&nbsp; colon,&nbsp; and&nbsp; intravenous&nbsp; contrast&nbsp; material was administered [90].</p>References:

<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>97. Copel L, Sosna J, Kruskal JB, Raptopoulos V, Farrell RJ, Morrin MM. CT colonography in 546 patients with incomplete colonoscopy. Radiology. 2007;244(2):471-478.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>98. Spada C, Hassan C, Barbaro B, et al. Colon capsule versus CT colonography in patients with incomplete colonoscopy: a prospective, comparative trial. Gut. 2015;64(2):272-281.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>99. Pullens HJ, van Leeuwen MS, Laheij RJ, Vleggaar FP, Siersema PD. CT-colonography after incomplete colonoscopy: what is the diagnostic yield? Dis Colon Rectum. 2013;56(5):593-599.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>100. Theis J, Kim DH, Lubner MG, Munoz del Rio A, Pickhardt PJ. CT colonography after incomplete optical colonoscopy: &nbsp;bowel &nbsp;preparation &nbsp; quality &nbsp;at &nbsp;same-day &nbsp; vs. &nbsp;deferred &nbsp;examination. &nbsp; Abdom &nbsp;Radiol &nbsp;(NY). &nbsp; 2016;41(1):10-18.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>101. Kao KT, Tam M, Sekhon H, Wijeratne R, Haigh PI, Abbas MA. Should barium enema be the next step following an incomplete colonoscopy? Int J Colorectal Dis. 2010;25(11):1353-1357.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>102. &nbsp;Brown &nbsp; AL, &nbsp;Skehan &nbsp;SJ, &nbsp; Greaney &nbsp;T, &nbsp;Rawlinson &nbsp; J, &nbsp;Somers &nbsp;S, &nbsp; Stevenson &nbsp;GW. &nbsp;Value &nbsp; of &nbsp;double-contrast &nbsp;barium &nbsp; &nbsp;enema &nbsp; performed &nbsp; immediately &nbsp; &nbsp;after &nbsp; incomplete &nbsp; colonoscopy. &nbsp; AJR &nbsp; &nbsp;Am &nbsp; J &nbsp; Roentgenol. &nbsp; &nbsp;2001;176(4):943-945.&nbsp;</strong></p>
<p style='margin-top:0in;margin-right:0in;margin-bottom:8.0pt;margin-left:0in;line-height:107%;font-size:15px;font-family:"Calibri",sans-serif;'><strong>103. &nbsp;Martinez &nbsp; F, &nbsp;Kondylis &nbsp;P, &nbsp; Reilly &nbsp;J. &nbsp;Limitations &nbsp; of &nbsp;barium &nbsp;enema &nbsp; performed &nbsp;as &nbsp;an &nbsp; adjunct &nbsp;to &nbsp;incomplete &nbsp; colonoscopy. Dis Colon Rectum. 2005;48(10):1951-1954. 104. &nbsp;Hartmann &nbsp; D, &nbsp;Bassler &nbsp;B, &nbsp; Schilling &nbsp;D, &nbsp;et &nbsp; al. &nbsp;Incomplete &nbsp;conventional &nbsp; colonoscopy: &nbsp;magnetic &nbsp;resonance &nbsp; colonography in the evaluation of the proximal colon. Endoscopy. 2005;37(9):816-820.</strong></p>
</body>
</html>